These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23340965)

  • 1. A label-free DC impedance-based microcytometer for circulating rare cancer cell counting.
    Choi H; Kim KB; Jeon CS; Hwang I; Lee S; Kim HK; Kim HC; Chung TD
    Lab Chip; 2013 Mar; 13(5):970-7. PubMed ID: 23340965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-selective collection of circulating tumor cells using Vortex technology.
    Sollier E; Go DE; Che J; Gossett DR; O'Byrne S; Weaver WM; Kummer N; Rettig M; Goldman J; Nickols N; McCloskey S; Kulkarni RP; Di Carlo D
    Lab Chip; 2014 Jan; 14(1):63-77. PubMed ID: 24061411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.
    Weissenstein U; Schumann A; Reif M; Link S; Toffol-Schmidt UD; Heusser P
    BMC Cancer; 2012 May; 12():206. PubMed ID: 22646670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technologies for detection of circulating tumor cells: facts and vision.
    Alix-Panabières C; Pantel K
    Lab Chip; 2014 Jan; 14(1):57-62. PubMed ID: 24145967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
    Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
    de Wit S; van Dalum G; Lenferink AT; Tibbe AG; Hiltermann TJ; Groen HJ; van Rijn CJ; Terstappen LW
    Sci Rep; 2015 Jul; 5():12270. PubMed ID: 26184843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
    Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP
    Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
    Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
    Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood.
    Park JM; Lee JY; Lee JG; Jeong H; Oh JM; Kim YJ; Park D; Kim MS; Lee HJ; Oh JH; Lee SS; Lee WY; Huh N
    Anal Chem; 2012 Sep; 84(17):7400-7. PubMed ID: 22881997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.